Press releaseGlobe Newswire
Prophase Labs
PRPH · NASDAQ
$0.0094+$0.0009 (+10.59%)TodayMarket closed ·
Prev close $0.0085
Latest news
- Press releaseGlobe Newswire
ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity
- Press releaseGlobe Newswire
ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative
- Press releaseGlobe Newswire
Join ProPhase Labs' Exclusive Live Investor Webinar and Q&A Session on February 3rd
- Press releaseGlobe Newswire
ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture
- Press releaseGlobe Newswire
ProPhase Labs Uplists from Pink Sheets to OTC Market
- Press releaseGlobe Newswire
ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value
- NewsAvi Kapoor
Dow Gains Over 200 Points; Conagra Shares Fall After Q2 Results
- Press releaseGlobe Newswire
From Super Fibers to Super Deals: Science, Scale, and Strategic Capital Shape the Morning Tape
- Press releaseGlobe Newswire
ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsAvi Kapoor
Why Vision Marine Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Join ProPhase Labs' Exclusive Live Investor Webinar and Q&A Session on December 1
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releaseGlobe Newswire
ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.
- News
Earnings Scheduled For November 19, 2025
- News
A Peek at ProPhase Labs's Future Earnings
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releaseGlobe Newswire
ProPhase Labs Engages RedChip Companies to Lead Investor Relations Efforts
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releasePRNewswire
Biotech Stocks Rally as Oncology Market Targets $866B by 2034
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Press releasePRNewswire
Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going
- Press releaseGlobe Newswire
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025
- News
ProPhase Labs's Earnings Outlook
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
An Overview of ProPhase Labs's Earnings
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
ProPhase Labs Announces Closing of Public Offering of Common Stock
- News
ProPhase Labs's Earnings: A Preview
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- NewsAvi Kapoor
S&P 500 Tops 6,000; Sezzle Shares Spike Higher
- NewsAvi Kapoor
Dow Tops 44,000; US Consumer Sentiment Increases In November
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- NewsAvi Kapoor
US Stocks Mixed; Fluor Earnings Miss Views
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- NewsAvi Kapoor
Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
- Press releaseGlobe Newswire
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.